A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (ar2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma
Hematological oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological oncology(2023)